These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 5783103)
1. [Changes in the amino acid pool in multiple myelomas]. Stacher A; Stöckl W; Weiser M Blut; 1969 May; 19(2):73-8. PubMed ID: 5783103 [No Abstract] [Full Text] [Related]
2. [Disease and therapy-dependent changes in the concentration of free amino acids in the plasma in multiple myelomas]. Stacher A; Stöckl W; Weiser M Wien Z Inn Med; 1967; 48(4):152-60. PubMed ID: 5620274 [No Abstract] [Full Text] [Related]
3. Amyloid myopathy and myeloma: response to treatment. Sheehan-Dare RA; Simmons AV Postgrad Med J; 1987 Feb; 63(736):141-2. PubMed ID: 3671242 [TBL] [Abstract][Full Text] [Related]
4. Combined chemotherapy versus melphalan and prednisolone for treatment of myelomatosis. Gregory WM; Richards MA; Malpas JS Lancet; 1992 May; 339(8805):1353-4. PubMed ID: 1350010 [No Abstract] [Full Text] [Related]
5. Intermittent melphalan and prednisolone therapy in plasma cell myeloma. Mellstedt H; Björkholm M; Holm G Acta Med Scand; 1977; 202(1-2):5-9. PubMed ID: 899883 [TBL] [Abstract][Full Text] [Related]
6. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime. Azam L; Delamore IW Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684 [No Abstract] [Full Text] [Related]
7. [The treatment of myelomas with melphalan]. Meshaka G; Seligmann M; Jacquillat C; Basch A; Bernard J Presse Med (1893); 1967 Nov; 75(46):2301-6. PubMed ID: 6054149 [No Abstract] [Full Text] [Related]
8. Progress in the treatment of multiple myeloma. Kumar S Lancet; 2006 Mar; 367(9513):791-2. PubMed ID: 16530557 [No Abstract] [Full Text] [Related]
9. Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma. Taha IA; Ahmad RA; Gray H; Roberts CI; Rogers HJ Cancer Chemother Pharmacol; 1982; 9(1):57-60. PubMed ID: 7139852 [TBL] [Abstract][Full Text] [Related]
10. Intensive therapy for myeloma. McElwain TJ; Meldrum M; Gore ME; Millar BC; Malpas JS Pathol Biol (Paris); 1990 Oct; 38(8):830. PubMed ID: 2274375 [No Abstract] [Full Text] [Related]
11. Melphalan plus prednisolone in the treatment of multiple myeloma. Begum M; Akther A; Khan KH; Kaiser MS; Rahman MJ; Alam MN Mymensingh Med J; 2012 Jan; 21(1):93-7. PubMed ID: 22314461 [TBL] [Abstract][Full Text] [Related]
12. Drugs for myeloma. Malpas JS; Parker D Br Med J; 1978 Aug; 2(6136):563. PubMed ID: 698569 [No Abstract] [Full Text] [Related]
13. [Results of the treatment of myeloma with a vincristine-melphalan combination]. Roux H; d'Omezon Y; Gaborit P; Eisinger F; Serratrice G Rev Rhum Mal Osteoartic; 1979; 46(7-9):443-8. PubMed ID: 315613 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of multiple myeloma. Results of sequential treatment with melphalan-prednisolone and the M2 protocol]. Steinke B; Busch FW; Stapelfeld S; Ostendorf P; Waller HD Dtsch Med Wochenschr; 1984 Jun; 109(26):1015-9. PubMed ID: 6547386 [TBL] [Abstract][Full Text] [Related]
16. Fragments of Bence-Jones proteins: products of degradation or of synthesis by plasmocytoma cells? Wetter O Klin Wochenschr; 1970 Apr; 48(8):482-4. PubMed ID: 5534829 [No Abstract] [Full Text] [Related]
17. Case report of plasma cell myeloma. Scarlett JD Am J Clin Pathol; 1991 Mar; 95(3):437. PubMed ID: 1996555 [No Abstract] [Full Text] [Related]
18. Melphalan kinetics in hyperthermic isolation perfusion of the extremities. Loos U; Musch E; Rauschecker H; Willenbrock C J Chemother; 1989 Jul; 1(4 Suppl):1246-7. PubMed ID: 16312851 [No Abstract] [Full Text] [Related]